L&K Biomed Ltd. (KOSDAQ:156100)
South Korea · Delayed Price · Currency is KRW 4,775.00
-205.00 (-4.12%)
At close: Nov 13, 2026
L&K Biomed Market Cap
L&K Biomed has a market cap or net worth of 106.73 billion as of November 13, 2026. It is the 26,258th most valuable company in the world and the 1,152nd biggest in South Korea. Its market cap has decreased by 44.59% in one year.
Market Cap
106.73B
Enterprise Value
107.50B
Revenue
39.94B
Global Rank
Country Rank
#1,152 South Korea
PE Ratio
37.14
ChartMarket Cap Chart
Since November 30, 2016, L&K Biomed's market cap has decreased from 114.44B to 106.73B, a decrease of -6.74%. That is a compound annual growth rate of -0.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 106.73B | -60.85% |
| Dec 30, 2025 | 272.58B | 106.21% |
| Dec 30, 2024 | 132.18B | -34.87% |
| Dec 28, 2023 | 202.96B | 89.01% |
| Dec 29, 2022 | 107.38B | -25.42% |
| Dec 30, 2021 | 143.97B | -72.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Next Biomedical | 234.66B |
| ASTERASYS Co.,Ltd | 177.41B |
| Mezoo | 167.50B |
| MEDIANA Co.,Ltd | 137.65B |
| Remed | 73.16B |
| Hironic | 66.90B |
| SELVAS Healthcare | 58.25B |
| DRGEM | 53.66B |